Literature DB >> 1634069

Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group).

G Meucci1, M Vecchi, G Torgano, M Arrigoni, A Prada, F Rocca, M Curzio, A Pera, R de Franchis.   

Abstract

To assess the familial aggregation of inflammatory bowel disease (IBD) in Italy, the family pedigrees of 411 patients with ulcerative colitis (UC) and 241 patients with Crohn's disease (CD) seen at 14 participating hospitals were studied. Sufficient information was obtained on 97% of 3752 first-degree relatives, 80% of 8869 second-degree relatives, and 74% of 5791 cousins. Thirty-six propositi (5.52%) had a total of 44 affected relatives (16 CD, 28 UC). The prevalence of IBD was higher in first- than in second-degree relatives and cousins (791, 112, and 163 in 100,000, respectively). A strong intrafamilial disease concordance was observed, with 26 cases of UC and 6 of CD among relatives of UC patients and 10 cases of CD and 2 of UC among relatives of CD patients. The prevalence of UC among first-degree relatives of UC patients and that of CD among first-degree relatives of CD patients was 680 and 531 in 100,000, respectively. In conclusion, there is a high degree of familial aggregation for IBD in Italy, with a strong intrafamilial disease concordance.

Entities:  

Mesh:

Year:  1992        PMID: 1634069     DOI: 10.1016/0016-5085(92)90841-l

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

Review 1.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 2.  Family and twin studies in inflammatory bowel disease.

Authors:  Leena Halme; Paulina Paavola-Sakki; Ulla Turunen; Maarit Lappalainen; Martti Farkkila; Kimmo Kontula
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 3.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

4.  Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease.

Authors:  I Naom; J Lee; D Ford; S J Bowman; J S Lanchbury; I Haris; S V Hodgson; D Easton; J Lennard-Jones; C G Mathew
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

Review 5.  Rare and common variant discovery in complex disease: the IBD case study.

Authors:  Guhan R Venkataraman; Manuel A Rivas
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

6.  Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch.

Authors:  Bo Shen; Feza H Remzi; Jeffrey P Hammel; Bret A Lashner; Charles L Bevins; Ian C Lavery; Jan Wehkamp; Victor W Fazio
Journal:  Inflamm Bowel Dis       Date:  2009-02       Impact factor: 5.325

7.  Familial aggregation of inflammatory bowel disease in a Mediterranean area.

Authors:  C Cipolla; A Magliocco; L Oliva; M Cottone
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

8.  Crohn's disease severity in familial and sporadic cases.

Authors:  F Carbonnel; G Macaigne; L Beaugerie; J P Gendre; J Cosnes
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

9.  Relationship between site of disease and familial occurrence in Crohn's disease.

Authors:  M Cottone; C Brignola; M Rosselli; L Oliva; C Belloli; C Cipolla; A Orlando; G De Simone; M R Aiala; R Di Mitri; G Gatto; A Buccellato
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

10.  Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.

Authors:  Weici Zhang; Masanobu Tsuda; Guo-Xiang Yang; Koichi Tsuneyama; Guanghua Rong; William M Ridgway; Aftab A Ansari; Richard A Flavell; Ross L Coppel; Zhe-Xiong Lian; M Eric Gershwin
Journal:  Hepatology       Date:  2010-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.